GTBP
GT Biopharma Inc. Common Stock
stockNASDAQ
At CloseOct 27, 2026 3:59:47 PM EDT
5.59USD+10.355%(+0.52)101,748
Pre-marketOct 27, 2026 9:29:30 AM EDT
5.68USD+12.032%(+0.61)
After-hoursOct 27, 2026 4:09:30 PM EDT
5.50USD-1.698%(-0.10)
Loading…
Loading…
10.10M
Healthcare
Biotechnology
HQ
Brisbane, CA, USA
Previous Close
$5.07
Beta
1.57
52-Week High
$28.75 2025-11-14
52-Week Low
$4.91 2026-09-08
SMA 50
$6.88
SMA 200
$9.98
Avg. Vol 10D
75,119
Avg. Vol 30D
67,781
Avg. Vol 90D
56,952
Relative Vol
1.36
1.80M
1.34M
74.19%
278,799
20.83%
7.22
44%/56%
46.57%
33.75%
509.9800%
1,738
6,667
42,579
Nov 13, 2026 (17d)
Sep 8, 2026 · 1-for-25 (reverse)
-4.8M
42.68
Oct 26, 2026
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting · 
GlobeNewswire Inc.
Sep 15, 2026
GT Biopharma receives FDA clearance for myeloma trial · 
Investing.com
GTBP Profile
using our proprietary platform technology, gt biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute myeloid leukemia, myeloid dysplastic syndrome, and multiple solid tumors by leveraging our proprietary nk cell engager (trike) platform technology. (nasdaq: gtbp)
GTBP Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 7.31 | 2026-10-20 | -23.39% | -10.162 |
| 1M | 6.80 | 2026-09-28 | -17.65% | 0.917 |
| 3M | 8.35 | 2026-07-27 | -32.95% | 2.113 |
| 6M | 7.00 | 2026-04-27 | -19.97% | 2.656 |
| 1Y | 17.36 | 2025-10-27 | -67.74% | 1.568 |
| 2Y | 82.50 | 2024-10-28 | -93.21% | — |
| 5Y | 4,657.50 | 2021-10-27 | -99.88% | 0.243 |
GTBP Stock Summary
GT Biopharma Inc. Common Stock (NASDAQ:GTBP) stock price today is $5.60, and today's volume is 92,330. GTBP is up 10.454% today. The 30 day average volume is 67,781. GTBP market cap is $10.10M with 1.80M shares outstanding.